Clinical Trial Update: Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i. [Phase 2]

View source ↗

Summary

This document reports Phase 2 efficacy and safety results for HRS-7535 tablets in adults with Type 2 diabetes poorly controlled on metformin and SGLT2 inhibitor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HRS-7535 tablets (HRS-7535)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED